In patients with heart failure with a preserved ejection fraction, tirzepatide reduces hospitalizations and the need for urgent therapy but not mortality

There's more to see -- the rest of this topic is available only to subscribers.

All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.